Stay updated on Nivolumab in Advanced SqNSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.

Latest updates to the Nivolumab in Advanced SqNSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check27 days agoChange DetectedThe name 'PPD Development, LP' has been updated to a different case format, changing from all uppercase to title case.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has been updated to include new information about a clinical trial for Non-Small Cell Lung Cancer, specifically mentioning the EudraCT number and collaborators, while significant details about the study's purpose and criteria have been removed.SummaryDifference11%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Nivolumab in Advanced SqNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.